“This last year has been a milestone for both the OTC markets and for Quantifi. The markets are starting to look towards the future as uncertainty is resolved by new regulations coming into effect,” comments Rohan Douglas, CEO of Quantifi. “Within this environment, Quantifi has had one of its strongest years to date with a 44% growth in new business balanced across all regions and sectors.”
Matching strong client growth, Quantifi has increased global staff by 48% with additional support, implementation, research, development, and sales hires. In addition, Quantifi has opened new offices in Paris and Frankfurt to capitalise on new opportunities in these regions and to better serve clients locally. To round off a solid 2013 Quantifi was named ‘category leader’ in the Chartis RiskTech Quadrant for Buy-Side Analytics. This is a strong endorsement of the positioning and value of our solutions.
Many of the regulatory changes resulting from the credit crisis are now affecting market participants. With several major version releases in 2013, Quantifi continues to address key client needs including support for CVA, Central Counterparty Clearing (CCP), margin replication, OIS discounting, regulatory reporting, PFE limit management, and funding costs analysis such as FVA and COVA.
Mr Douglas continues “2014 promises to be a year of opportunities as well as challenges and I believe we are well positioned to take advantage of the changes in the OTC markets. As Quantifi continues to partner with clients, we look forward to providing long term value as well as share in mutual success.”